Equities research analysts forecast that Aterian, Inc. (NASDAQ:ATER – Get Rating) will report earnings of ($0.18) per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Aterian’s earnings, with estimates ranging from ($0.23) to ($0.12). Aterian reported earnings of ($0.80) per share in the same quarter last year, which suggests a positive year over year growth rate of 77.5%. The business is scheduled to announce its next earnings results on Monday, January 1st.
According to Zacks, analysts expect that Aterian will report full year earnings of ($1.19) per share for the current fiscal year, with EPS estimates ranging from ($1.38) to ($0.99). For the next financial year, analysts forecast that the business will report earnings of ($0.37) per share, with EPS estimates ranging from ($0.40) to ($0.34). Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow Aterian.
Aterian (NASDAQ:ATER – Get Rating) last posted its quarterly earnings results on Monday, May 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.25). Aterian had a negative net margin of 80.79% and a negative return on equity of 33.08%. During the same quarter last year, the business posted ($0.64) EPS.
NASDAQ:ATER traded down $0.22 on Monday, hitting $3.13. The company had a trading volume of 5,426,227 shares, compared to its average volume of 15,161,738. The stock has a market capitalization of $194.34 million, a price-to-earnings ratio of -0.60 and a beta of 1.25. The firm has a 50 day moving average of $3.86 and a two-hundred day moving average of $4.01. Aterian has a 52 week low of $2.10 and a 52 week high of $21.07.
In related news, insider Yaniv Zion Sarig sold 166,127 shares of the firm’s stock in a transaction dated Wednesday, March 23rd. The shares were sold at an average price of $2.68, for a total transaction of $445,220.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 4.80% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of ATER. Royal Bank of Canada bought a new stake in shares of Aterian in the second quarter valued at approximately $65,000. Bank of America Corp DE bought a new stake in shares of Aterian in the second quarter valued at approximately $170,000. Morgan Stanley bought a new stake in shares of Aterian in the second quarter valued at approximately $5,227,000. Deutsche Bank AG raised its position in shares of Aterian by 225.6% in the third quarter. Deutsche Bank AG now owns 41,903 shares of the company’s stock valued at $454,000 after purchasing an additional 29,032 shares during the period. Finally, State Board of Administration of Florida Retirement System purchased a new position in Aterian during the third quarter valued at approximately $124,000. 17.13% of the stock is currently owned by institutional investors.
Aterian Company Profile (Get Rating)
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products.
Recommended Stories
- Get a free copy of the StockNews.com research report on Aterian (ATER)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Will John Deere’s Earnings Help to Calm the Markets?
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Lowe’s Companies Has Not Bottomed
Get a free copy of the Zacks research report on Aterian (ATER)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.